In addition, DCs isolated from NDV-GP-treated MC38-OVA tumors rather than PBS- or NDV-WT-treated ones were more efficient in priming the tumor-specific OT-I CD8+ T cell response (Extended Data Fig. 8e,f). Here, CD8A is linked to neoplasm.